A groundbreaking shift in our drug policy has taken place, as the regulators allow the legalization of psilocybin mushrooms for therapeutic treatment. Until now, these substances were severely restricted, but a growing body of research suggests they could offer aid for mental health illnesses like depression. The new policy represents a key step to